A detailed history of National Bank Of Canada transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 5,502 shares of ALDX stock, worth $26,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,502
Previous 5,502 -0.0%
Holding current value
$26,354
Previous $29,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.19 - $6.32 $6 - $12
2 Added 0.04%
5,502 $29,000
Q1 2024

May 13, 2024

BUY
$2.77 - $4.22 $15,235 - $23,210
5,500 New
5,500 $17,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.